Skip to main content
Top
Published in: Neurosurgical Review 1/2021

01-02-2021 | Antibiotic | Review

Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis

Authors: Alexandros G. Brotis, Isaac Churis, Marios Karvouniaris

Published in: Neurosurgical Review | Issue 1/2021

Login to get access

Abstract

Direct delivery of antibiotics to the ventricular system offers an alternative for the management of nosocomial meningitis. However, the available literature frequently results in controversial findings regarding its safety. The present meta-analysis aimed at summarizing the risk of local complications after the administration of intraventricular/intrathecal (IVT/IT) antibiotics for the treatment of ventriculitis/meningitis (VM) associated with gram-negative pathogens. We systematically searched the medical literature from 1964 until July 2018, for clinical studies reporting on complications after the index treatment. The quality of the eligible studies was classified as “high,” “moderated,” and “low” for randomized controlled trials, observational studies, and case series, respectively. The results were summarized as pooled frequencies, estimated by the random- or fixed-effects models, according to the inter-study heterogeneity. The publication bias was visualized in trim-and-fill funnel plots. Τhe analysis included twenty-three primary studies with 229 patients. The overall complication rate was as high as 0.13 (95% CI 0.08; 0.19, I2 = 9%); chemical meningitis and seizures represented the majority of the complications, with an occurrence rate of 0.11 (95% CI 0.07; 0.17, I2 = 0%) and 0.07 (95% CI 0.04; 0.12; I2 = 0%), respectively. The meta-analysis was based on studies of “moderate” and “low” reporting quality, while the publication bias after inspecting of the funnel plots revealed significant asymmetry. The present review denotes the absence of large, high-quality studies in the field. Nevertheless, IVT/IT was associated with moderate morbidity, mainly attributed to chemical meningitis and seizures. Further high-quality studies are still required before this therapeutic modality becomes broadly established.
Literature
1.
go back to reference Beer R, Lackner P, Pfausler B, Schmutzhard E (2008) Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 255(11):1617–1624PubMedCrossRef Beer R, Lackner P, Pfausler B, Schmutzhard E (2008) Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 255(11):1617–1624PubMedCrossRef
2.
go back to reference Kumta N, Roberts JA, Lipman J, Cotta MO (2018) Antibiotic distribution into cerebrospinal fluid: can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 57(4):439–454PubMedCrossRef Kumta N, Roberts JA, Lipman J, Cotta MO (2018) Antibiotic distribution into cerebrospinal fluid: can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 57(4):439–454PubMedCrossRef
3.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281CrossRefPubMed
4.
go back to reference Kaiser AB, McGee ZA (1975) Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 293(24):1215–1220PubMedCrossRef Kaiser AB, McGee ZA (1975) Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 293(24):1215–1220PubMedCrossRef
5.
go back to reference Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E (2013) Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 57(4):1938–1940PubMedPubMedCentralCrossRef Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D, Zakynthinos E (2013) Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 57(4):1938–1940PubMedPubMedCentralCrossRef
6.
go back to reference Tunkel AR et al (2017) Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis Tunkel AR et al (2017) Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis
7.
go back to reference Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E, Fountas K (2016) Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir 158(3):603–610 discussion 610PubMedCrossRef Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E, Fountas K (2016) Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir 158(3):603–610 discussion 610PubMedCrossRef
8.
go back to reference Moon C, Kwak YG, Kim BN, Kim ES, Lee CS (2013) Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother 19(5):916–919PubMedCrossRef Moon C, Kwak YG, Kim BN, Kim ES, Lee CS (2013) Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother 19(5):916–919PubMedCrossRef
9.
go back to reference Snavely SR, Hodges GR (1984) The neurotoxicity of antibacterial agents. Ann Intern Med 101(1):92–104PubMedCrossRef Snavely SR, Hodges GR (1984) The neurotoxicity of antibacterial agents. Ann Intern Med 101(1):92–104PubMedCrossRef
10.
go back to reference Watanabe I, Hodges GR, Dworzack DL, Kepes JJ, Duensing GF (1978) Neurotoxicity of intrathecal gentamicin: a case report and experimental study. Ann Neurol 4(6):564–572PubMedCrossRef Watanabe I, Hodges GR, Dworzack DL, Kepes JJ, Duensing GF (1978) Neurotoxicity of intrathecal gentamicin: a case report and experimental study. Ann Neurol 4(6):564–572PubMedCrossRef
11.
go back to reference Cook AM, Mieure KD, Owen RD, Pesaturo AB, Hatton J (2009) Intracerebroventricular administration of drugs. Pharmacotherapy 29(7):832–845PubMedCrossRef Cook AM, Mieure KD, Owen RD, Pesaturo AB, Hatton J (2009) Intracerebroventricular administration of drugs. Pharmacotherapy 29(7):832–845PubMedCrossRef
12.
go back to reference Falagas ME, Bliziotis IA, Tam VH (2007) Intraventricular or intrathecal use of polymyxins in patients with gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 29(1):9–25PubMedCrossRef Falagas ME, Bliziotis IA, Tam VH (2007) Intraventricular or intrathecal use of polymyxins in patients with gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 29(1):9–25PubMedCrossRef
13.
go back to reference Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 41(6):499–508PubMedCrossRef Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 41(6):499–508PubMedCrossRef
14.
go back to reference Shamseer L et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647PubMedCrossRef Shamseer L et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647PubMedCrossRef
16.
go back to reference Graybill JR, Mann J, Charache P (1973) Intrathecal gentamicin in treatment of bacterial meningitis. Johns Hopkins Med J 133(1):51–56PubMed Graybill JR, Mann J, Charache P (1973) Intrathecal gentamicin in treatment of bacterial meningitis. Johns Hopkins Med J 133(1):51–56PubMed
17.
go back to reference Rahal JJ et al (1974) Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med 290(25):1394–1398PubMedCrossRef Rahal JJ et al (1974) Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med 290(25):1394–1398PubMedCrossRef
18.
go back to reference Bray DA, Calcaterra TC (1976) Pseudomonas meningitis complicating head and neck surgery. Laryngoscope 86(9):1386–1390PubMedCrossRef Bray DA, Calcaterra TC (1976) Pseudomonas meningitis complicating head and neck surgery. Laryngoscope 86(9):1386–1390PubMedCrossRef
19.
go back to reference Gilbert VE, Beals JD Jr, Natelson SE, Tyler WA (1986) Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics. Neurosurgery 18(4):402–406PubMedCrossRef Gilbert VE, Beals JD Jr, Natelson SE, Tyler WA (1986) Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics. Neurosurgery 18(4):402–406PubMedCrossRef
20.
go back to reference Quinn AL, Parada JP, Belmares J, O’Keefe JP (2005) Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother 39(5):949–952PubMedCrossRef Quinn AL, Parada JP, Belmares J, O’Keefe JP (2005) Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection. Ann Pharmacother 39(5):949–952PubMedCrossRef
21.
go back to reference Nguyen MH, Harris SP, Muder RR, Pasculle AW (1994) Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery 35(5):851–855 discussion 855PubMedCrossRef Nguyen MH, Harris SP, Muder RR, Pasculle AW (1994) Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery 35(5):851–855 discussion 855PubMedCrossRef
22.
go back to reference Karakitsos D, Paramythiotou E, Samonis G, Karabinis A (2006) Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand 50(10):1309–1310CrossRefPubMed Karakitsos D, Paramythiotou E, Samonis G, Karabinis A (2006) Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand 50(10):1309–1310CrossRefPubMed
23.
go back to reference Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK (2006) Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 58(5):1078–1081PubMedCrossRef Ng J, Gosbell IB, Kelly JA, Boyle MJ, Ferguson JK (2006) Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 58(5):1078–1081PubMedCrossRef
24.
go back to reference Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61(4):908–913PubMedCrossRef Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA (2008) Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 61(4):908–913PubMedCrossRef
25.
go back to reference López-Alvarez B, Martín-Láez R, Fariñas MC, Paternina-Vidal B, García-Palomo JD, Vázquez-Barquero A (2009) Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir 151(11):1465–1472PubMedCrossRef López-Alvarez B, Martín-Láez R, Fariñas MC, Paternina-Vidal B, García-Palomo JD, Vázquez-Barquero A (2009) Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir 151(11):1465–1472PubMedCrossRef
26.
go back to reference Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2010) Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect 16(7):888–894PubMedCrossRef Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2010) Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect 16(7):888–894PubMedCrossRef
27.
go back to reference Imberti R, Cusato M, Accetta G, Marinò V, Procaccio F, del Gaudio A, Iotti GA, Regazzi M (2012) Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother 56(8):4416–4421PubMedPubMedCentralCrossRef Imberti R, Cusato M, Accetta G, Marinò V, Procaccio F, del Gaudio A, Iotti GA, Regazzi M (2012) Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother 56(8):4416–4421PubMedPubMedCentralCrossRef
28.
go back to reference Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H (2013) Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents 41(5):480–483PubMedCrossRef Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H (2013) Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents 41(5):480–483PubMedCrossRef
29.
go back to reference Wang JH et al (2014) Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 47(3):204–210PubMedCrossRef Wang JH et al (2014) Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 47(3):204–210PubMedCrossRef
30.
go back to reference De Bonis P et al (2016) Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur J Neurol 23(1):68–75PubMedCrossRef De Bonis P et al (2016) Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur J Neurol 23(1):68–75PubMedCrossRef
31.
go back to reference Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G, Paul M (2016) Intrathecal or intraventricular therapy for post-neurosurgical gram-negative meningitis: matched cohort study. Clin Microbiol Infect 22(1):66–70PubMedCrossRef Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G, Paul M (2016) Intrathecal or intraventricular therapy for post-neurosurgical gram-negative meningitis: matched cohort study. Clin Microbiol Infect 22(1):66–70PubMedCrossRef
32.
go back to reference Gilbert B, Morrison C (2017) Evaluation of intraventricular colistin utilization: a case series. J Crit Care 40:161–163PubMedCrossRef Gilbert B, Morrison C (2017) Evaluation of intraventricular colistin utilization: a case series. J Crit Care 40:161–163PubMedCrossRef
33.
go back to reference Chusri S, Sakarunchai I, Kositpantawong N, Panthuwong S, Santimaleeworagun W, Pattharachayakul S, Singkhamanan K, Doi Y (2018) Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. Int J Antimicrob Agents 51(4):646–650PubMedCrossRef Chusri S, Sakarunchai I, Kositpantawong N, Panthuwong S, Santimaleeworagun W, Pattharachayakul S, Singkhamanan K, Doi Y (2018) Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. Int J Antimicrob Agents 51(4):646–650PubMedCrossRef
34.
35.
go back to reference Tsimogianni A, Alexandropoulos P, Chantziara V, Vassi A, Micha G, Lagiou F, Chinou E, Michaloudis G, Georgiou S (2017) Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit. Int J Antimicrob Agents 49(3):389–390PubMedCrossRef Tsimogianni A, Alexandropoulos P, Chantziara V, Vassi A, Micha G, Lagiou F, Chinou E, Michaloudis G, Georgiou S (2017) Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit. Int J Antimicrob Agents 49(3):389–390PubMedCrossRef
37.
go back to reference O, E., Practical guide to the meta-analysis of rare events. 2018 O, E., Practical guide to the meta-analysis of rare events. 2018
38.
go back to reference Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4(2):e4439PubMedPubMedCentralCrossRef Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4(2):e4439PubMedPubMedCentralCrossRef
39.
go back to reference Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G (2017) Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther 101(4):491–500PubMedCrossRef Lanvers-Kaminsky C, Zehnhoff-Dinnesen AA, Parfitt R, Ciarimboli G (2017) Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther 101(4):491–500PubMedCrossRef
40.
go back to reference Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE (1970) Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 72(6):857–868PubMedCrossRef Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE (1970) Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 72(6):857–868PubMedCrossRef
41.
go back to reference Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol 32(3):252–260PubMedCrossRef Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. Fundam Clin Pharmacol 32(3):252–260PubMedCrossRef
42.
go back to reference Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T (2005) Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 64(6):1086–1087PubMedCrossRef Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T (2005) Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 64(6):1086–1087PubMedCrossRef
43.
go back to reference Bargiacchi O, Rossati A, Car P, Brustia D, Brondolo R, Rosa F, Garavelli PL, de Rosa FG (2014) Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant gram negative bacteria: case reports and review. Infection 42(5):801–809PubMedCrossRef Bargiacchi O, Rossati A, Car P, Brustia D, Brondolo R, Rosa F, Garavelli PL, de Rosa FG (2014) Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant gram negative bacteria: case reports and review. Infection 42(5):801–809PubMedCrossRef
44.
go back to reference Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN (2018) The role of intraventricular antibiotics in the treatment of nosocomial ventriculitis/meningitis from gram-negative pathogens: a systematic review and meta-analysis. World Neurosurg 120:e637–e650PubMedCrossRef Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN (2018) The role of intraventricular antibiotics in the treatment of nosocomial ventriculitis/meningitis from gram-negative pathogens: a systematic review and meta-analysis. World Neurosurg 120:e637–e650PubMedCrossRef
Metadata
Title
Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis
Authors
Alexandros G. Brotis
Isaac Churis
Marios Karvouniaris
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Neurosurgical Review / Issue 1/2021
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-019-01226-w

Other articles of this Issue 1/2021

Neurosurgical Review 1/2021 Go to the issue